Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionCombination of 10% sodium phenylacetate and 10% sodium benzoate
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationUrea cycle disorder (UCD)
Indication DetailsTreat urea cycle disorder (UCD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today